
Sign up to save your podcasts
Or


In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.
By American College of Cardiology4.4
3737 ratings
In this podcast, Kim Birtcher, Seth Martin, Donald Lloyd-Jones, and Lynne Braun discuss what optimal lipid therapy and management look like in a post-ezetimibe world. They answer patient and colleague questions about lowering low-density lipoprotein (LDL) and debate if LDL can ever be too low. This is a rebroadcast from the clinical focus session at ACC.19.

317 Listeners

505 Listeners

162 Listeners

39 Listeners

897 Listeners

19 Listeners

2 Listeners

3,365 Listeners

136 Listeners

1,154 Listeners

65 Listeners

376 Listeners

17 Listeners

440 Listeners

33 Listeners